AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
Log in

CNSX:ISOLIsodiol International Stock Price, Forecast & News

$0.06
0.00 (0.00 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.06
Now: $0.06
$0.07
50-Day Range
$0.07
MA: $0.08
$0.16
52-Week Range
$0.05
Now: $0.06
$1.69
Volume513,765 shs
Average Volume164,946 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer products and solutions in Canada, Latin America, Asia, and Europe. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; and producing bioactive cannabinoids that are used in pharmaceutical applications, including life-threatening and non-life-threatening illnesses, as well as the provision of apparel and merchandising solutions. The company is headquartered in Vancouver, Canada.
Read More
Isodiol International logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars


Industry, Sector and Symbol

Industry Software - Application
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone800-844-1468

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees57
Next Earnings DateN/A
OptionableNot Optionable

Receive ISOL News and Ratings via Email

Sign-up to receive the latest news and ratings for ISOL and its competitors with MarketBeat's FREE daily newsletter.

Isodiol International (CNSX:ISOL) Frequently Asked Questions

Has Isodiol International been receiving favorable news coverage?

News headlines about ISOL stock have trended negative on Tuesday, according to InfoTrie. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Isodiol International earned a coverage optimism score of -2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Isodiol International.

Who are some of Isodiol International's key competitors?

What other stocks do shareholders of Isodiol International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Isodiol International investors own include Eguana Technologies (EGT), Radient Technologies (RTI), Nemaska Lithium (NMX), Aurora Cannabis (ACB), Isodiol International (ISOLF), Momo (MOMO), Curaleaf (CURLF), Horizon Therapeutics (HZNP), Canopy Growth (WEED) and Aurora Cannabis (ACB).

Who are Isodiol International's key executives?

Isodiol International's management team includes the following people:
  • Mr. Marcos Agramont, CEO, Pres & Director
  • Mr. Soheil Samimi, Advisor
  • Mr. Eli Dusenbury, Chief Financial Officer
  • Mr. Patrick Edward Ogle J.D., L.L.M., COO & Director
  • Mr. Marvin Washington, VP of Bus. Devel. & Director

What is Isodiol International's stock symbol?

Isodiol International trades on the CNSX under the ticker symbol "ISOL."

How do I buy shares of Isodiol International?

Shares of ISOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Isodiol International's stock price today?

One share of ISOL stock can currently be purchased for approximately $0.06.

What is Isodiol International's official website?

The official website for Isodiol International is www.1mage.com.

How can I contact Isodiol International?

The company can be reached via phone at 800-844-1468.

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.